Biochemical and Other Techniques That Employ Yttrium and Scandium. Outlook

  • Chaim T. Horovitz
Chapter
Part of the Biochemistry of the Elements book series (BOTE, volume 13B)

Abstract

Much information has been accumulated in the last two decades about the abilities of scandium and yttrium to serve as inert markers in nutrition research and the investigation of metabolic processes; also, they serve as informative probes of the interactions of calcium, magnesium, aluminum, and other metals with molecules of biochemical interest.

Keywords

Human Tumor Xenograft Pulmonary Metastasectomy Japanese Patent Inert Marker Scandium Oxide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aburai, Y., 1991. Production of mineral water containing trace minerals for purposes of health, Japanese patent 03224690.Google Scholar
  2. Anderson, L. D., Frincke, J. M., Meyer, D. L., Sullivan, B. W., Battersby, T. R., and Kusnierz, E., 1989. Improvements relating to modified haptens as imaging and therapeutic agents, European patent 327365. CA 113:187358q.Google Scholar
  3. Anderson, W. T., and Strand, M., 1985. Stability, targeting and bio-distribution of 46Sc-and 67Ga-labeled MAb in erythroleukemic mice, Cancer Res. 45:2154–2158.Google Scholar
  4. Anderson-Berg, W. T., Squire, R. E., and Strand, M., 1987. Specific radioimmunotherapy using 90Y-labeled MAb in erythroleukemic mice, Cancer Res. 47:1905–1912.Google Scholar
  5. Andrews, J. C., Walker, S. C., Ackermann, R. J., Cotton, L. A., Ensminger, W. D., and Shapiro, B., 1994. Hepatic radioembolization with 90Y containing glass microspheres. Preliminary results and clinical follow-up, J. Nucl. Med. 35:1637–1644.Google Scholar
  6. Antoniw, P., Farnsworth, A. P. H., Turner, A., Haines, A. M. R., Mountain, A., Mackintosh, J., Shochat, D., Humm, J., Welt, S., Old, L. J., Yarranton, G. T., and King, D. J., 1996. Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with 90Y A33Ig and Tri-Fab, Br. I Cancer 714:513–524.Google Scholar
  7. Ariel, I. M., and Padula, G., 1984. Selective angiography as a means of delivering 90Y microspheres in the treatment of cancer, in: Interventional Nuclear Medicine (R. P. Spencer, ed.), Grune & Stratton, Orlando, pp. 15–34.Google Scholar
  8. ASM International Panel, 1988. Assessment of quality and material form of minor metals for the national defense stockpile, Final report, ASM International Panel, Washington, D.C.Google Scholar
  9. Association of the Dutch Chemical Industry and the Royal Society of Chemistry, Great Britain, 1991. The Periodic Table of Elements.Google Scholar
  10. Axen, C., and Janson, P. O., 1979. Diaphragmatic blood flow at various levels of ventilation in the rabbit, Acta Physiol. Scand. 106:1–3.Google Scholar
  11. Baisden, C. R., 1982. Nutrient compound, U.S. patent 4337245. CA 97:71338e.Google Scholar
  12. Ballandovich, V. S., 1991. Scandium acceptor in GH-SiC, Sou Phys. Semicond. 25:174–178.Google Scholar
  13. Barnard, D. J., 1973. A simpler radio-isotope method for the determination of faecal fat, Med. Lab. Technol. 30:239–244.Google Scholar
  14. Basse-Cathalinat, B., Blanquet, P., Collignon, G., and Mirande-Iriberry, J., 1968. Bone scintigraphy with 47Sc and the scintillation camera, J. Nucl. Med. 9:436–438.Google Scholar
  15. Bazin, M., Levaire, W., and Riglet, G., 1994. Seeds labeled with rare earth elements, Canadian patent 2120634. CA 122:128139g.Google Scholar
  16. Becker, C. D., Rusler, H., Biasiutti, F. D., and Baer, H. U., 1995. Congestive hypersplenism. Treatment by means of radioembolization of the spleen with 90Y, Radiology 195:183–186.Google Scholar
  17. Beverlo, H. B., Vanschadewijk, A., Bonnet, J., Vander Geest, R., Runia, R., Verwoerd, N. P., Vrolijk, J., Ploem, J. S., and Tanke, H. J., 1992. Preparation and microscopic visualization of multicolor luminescent immunophosphors, Cytometry 13:561–570.Google Scholar
  18. Bianco, J. A., Bakanauskas, J., Carlson, M., Jones, S., Moring, A., Alpert, J. S., and Klassen, V, 1988. Augmented uptake of 2-14C-D-deoxyglucose in reversibly-injured myocardium, Eur. J. Nucl. Med. 13:557–562.Google Scholar
  19. Brancate, R., Leoni, G., Trabucchi, G., and Cappelini, A., 1991. Histopathology of continuous wave Nd:YAG and diode laser cataract transscleral lesions in rabbit ciliary body, Invest. Ophthalmol. Visual Sci. 32:1586–1592.Google Scholar
  20. Brechbiel, M. W., and Gansow, O. A., 1991. Backbone-substituted DTPA ligands for 90Y, Bioconjug. Chem. 2:187–194.Google Scholar
  21. Brown, D. B., Obrien, W. J., and Schultz, R. O., 1994. The mechanism of ablation of corneal tissue by the Nd doped YLiF picosecond laser. Cornea 13:479–486.Google Scholar
  22. Buckel, W., 1991. Superconductivity, VCH, Weinheim.Google Scholar
  23. Bünzli, J. C, and Choppin, G. R., eds., 1989. Lanthanide Probes in Life, Chemical and Earth Sciences, Elsevier, Amsterdam.Google Scholar
  24. Burke, C. W., Doyle, F. H., Joplin, G. F., Arnot, R. N., Macerlean, D. P., and Fraser, T. R., 1973. Treatment of Cushing’s disease by pituitary implantation of radioactive gold and yttrium seeds, Quart. J. Med. 42:693–714.Google Scholar
  25. Caldwell, J. H., Martin, G. V., Link, J. M., Krohn, K. A., and Bassingthwaighte, J. B., 1990. Iodophenylpentadecanoic acid myocardial blood flow relationship during maximal exercise with coronary occlusion, J. Nucl. Med. 30:99–105.Google Scholar
  26. Cann, C. E., and Prussin, S. G., 1980. Possible parathyroid imaging using 67Ga and other aluminum analogues, J. Nucl. Med. 21:471–474.Google Scholar
  27. Cassar, J., Doyle, F. H., Lewis, P. D., Mashiter, K., Van Noorden, S., and Joplin, G. F., 1976. Treatment of Nelson’s syndrome by pituitary implantation of 90Y or 108Au, Br. Med. J. 2:269–272.Google Scholar
  28. Cheetham, A. K., 1994. Advanced inorganic materials. An open horizon. Science 264:794–795.Google Scholar
  29. Chinol, M., Paganelli, G., Sudati, F., Meares, C., and Fazio, F., 1997. Biodistribution in tumor-bearing mice of two 90Y-labeled biotins using three-step tumor targeting, Nucl. Med. Commun. 18:176–182.Google Scholar
  30. Christel, P., Meunier, A., Heller, M., Torre, J. P., and Peille, C. N., 1989. Mechanical properties and short-term in vivo evaluation of Y2O3-partially stabilized zirconia. J. Biomed. Mater. Res. 23:45–61.Google Scholar
  31. Cooper, M. M., Robbins, R. C, Goldman, C. K., Mirzadeh, S., Brechbiel, M. W., Stone, C. D., Gansow, O. A., Clark, R. E., and Waldmann, T. A., 1990. Use of 90Y-labeled anti-Tac antibody in primate xenograft transplantation, Transplantation 50:760–765.Google Scholar
  32. Coursey, B. M., Calhoun, J. M., and Cessna, J. T., 1993. Radioassays of 90Y used in nuclear medicine, Nucl. Med. Biol. 20:693–699.Google Scholar
  33. Cox, P. A., 1982. Transition Metal Oxides, Clarendon Press, Oxford.Google Scholar
  34. Dall, W, and Smith, D. M., 1977. Measurement of water drinking rates in marine Crustacea, J. Exp. Mar. Biol. Ecol. 30:199–208.Google Scholar
  35. Dawson, T. M., Ryan, P. F. J., Street, A. M., Robertson, R. L., Kalff, V, Kellys, M. J., and Cicuttini, F. M., 1994. Yttrium synovectomy in hemophilic arthropathy, Br. J. Rheumatol. 33:351–356.Google Scholar
  36. DeNardo, S. I, Gumerlock, P. H., Winthrop, M. D., Mack, P. C., Chi, S.-G., Lamborn, K. R., Shen, S., Miers, L. A., White, R. W, and DeNardo, G. L., 1995. 90Y chimeric L6 therapy of human breast cancer in nude mice, and apoptosis-related messenger RNA expression, Cancer Res. 55:5837s–5841s.Google Scholar
  37. Deshpande, S. V., DeNardo, S. I., Kukis, D. L., Moi, M. K., McCall, M. J., DeNardo, G. L., and Meares, C. F, 1990. 90Y-labeled MAb for therapy. Labeling by a new macrocyclic bifunctional chelating agent, J. Nucl. Med. 31:473–479.Google Scholar
  38. Diamandis, E. P., and Redshaw, R., 1995. Localization and therapy of nonprostatic endocrine cancer with agents directed against prostate-specific antigen, PCT patent 9502,424. CA 122:208793f.Google Scholar
  39. Dillehay, L. E., Mayer, R., Zhang, Y., Shay, Y, Song, S., Mackensen, D., and Williams, J., 1995. Prediction of tumor response to experimental radioimmuno-therapy with 90Y in nude mice, Biol. Phys. 33:417–427.Google Scholar
  40. Dzata, E K. A., and Loveland, W. D., 1982. Development of stable fluorescence tracers for use in small water systems, Nucl. Instrum. Methods 193:319–322.Google Scholar
  41. Edmonds, J., Smarts, R., Laurent, R., Butler, P., Brooks, P., Hoschl, R., Wiseman, J., George, S., Lovegrove, E., and Lambrecht, R., 1994. A comparative study of the safety and efficacy of 165Dy hydroxide macro-aggregate and 90Y silicate colloid in radiation synovectomy. Br. J. Rheumatol. 33:947–953.Google Scholar
  42. Edwards, E M., Kraushaar, J. J., Ristinen, R. A., and Rudolph, H., 1977. Use of 48Ca as stable isotope tracer analyzed by proton activation, Med. Phys. 4:58–65.Google Scholar
  43. Evans, C. H., 1990. Past, present and possible future clinical applications of the lanthanides, in: Biochemistry of the Lanthanides, Plenum Press, New York, pp. 391–425.Google Scholar
  44. Fenner, J., Moseley, H., Martin, W., and Wheatley, D. J., 1992. Strength of tissue bonds as a function of surface apposition, Lasers Med. Sci. 7:375–379.Google Scholar
  45. Fernandes, E. A. N., 1993. Scandium as tracer in the sugar and alcohol agro-industry, J. Radioanal. Nucl. Chem. 168:41–46.Google Scholar
  46. Filler, A. G., and Lever, A. M. L., 1996. Nucleic acid amplification using scandium and lanthanum ions, U.S.A. patent 5554498. BA 48:166119.Google Scholar
  47. Flaim, S. E, Nellis, S. H., Toggart, E. J., Drexler, H., Kanda, K., and Newman, E.D., 1984. Multiple simultaneous determination of hemodynamics and flow distribution in conscious rat, J. Pharmacol Methods 11:1–39.Google Scholar
  48. Franssen, M. J. A. M., Koenders, E. B., Boerbooms, A. M. T., Buijs, W. C. A. M., Lemmens, J. A. M., and Van De Putte L. B. A., 1997. Does application of radiographic contrast medium in radiation synovectomy influence the stability of 90Y colloid? Br. J. Rheumatol 36:506–508.Google Scholar
  49. Franz, K. A., Kehr, W G., Siggel, A., Wieczoreck, J., and Adam, W, 1989. Luminescent materials, in Ullmann’s Encyclopedia of Industrial Chemistry (B. Elvers et al., eds.), VCH, New York, Vol. A13, pp. 519–555.Google Scholar
  50. Frausto da Silva, J. J. R., and Williams, R. J. P., 1991. The Biological Chemistry of the Elements, The Inorganic Chemistry of Life, Clarendon Press, Oxford, pp. 545–551.Google Scholar
  51. Gansow, O. A., 1991. Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates, Nucl. Med. Biol. 18:369–381.Google Scholar
  52. Gärtner, G., Janiel, P., Crombeen, J. E., and Hasner, J., 1989. Top-layer scandate cathode by plasma activated CVD, Inst. Phys. Conf. Ser., No. 99, pp. 25–28.Google Scholar
  53. Georgi, J. R., 1982. Schistosoma monsoni: Quantification of skin penetration and early migration by differential external radioassay and autoradiography, Parasitology 84:263–281.Google Scholar
  54. Geschwind, H. J., Nakamura, E, Kvasnicka, J., and Dubois-Rande, J. L., 1993. Excimer and Ho:YAG laser coronary angioplasty. Am. Heart J. 125:510–522.Google Scholar
  55. Gladney, E. S., and Goode, E., 1979. Preparation of carrier free 47Sc by 47Ti(n,p) reaction with epithermal neutrons, Int. J. Appl. Radiat, Isot. 30:65.Google Scholar
  56. Gonzales, M. J., Smith, M., and Reinisch, L., 1990. Endotracheal tube safety with the Er:YAG laser, Ann. Otol Rhinol. Laryngol 991:553–556.Google Scholar
  57. Goodwin, D. A., Meares, C. E, Watanabe, N., McTigue, M., Chaova Pong, W, Ransone, C. M., Renn, O., Greiner, D. P., Kukis, D. L., and Kronenberger, S. L, 1994. Pharmacokinetics of pretargeted MAb 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-l,4,7-10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma. A model for 90Y radio-immunotherapy, Cancer Res. 54:5937–5946.Google Scholar
  58. Gray, B. N., Anderson, J. E., Burton, M. A., Van Hazel, G., Codde, J., Morgan, C., and Klemp, P., 1995. Regression of liver metastases following treatment with 90Y microspheres, Aus. N. Z. Surg. 62:105–110.Google Scholar
  59. Gray, D. H., and Vogt, J. R., 1974. NAA of stable heavy metals as multiple markers in nutritional monitoring, J. Agric. Food Chem. 22:144–146.Google Scholar
  60. Greiner, D. P., Hughes, K. A., and Meares, C. F., 1996. Radiolytic protein surface mapping, Biochem. Biophys. Res. Commun. 225:1006–1018.Google Scholar
  61. Gross, P. M., Marcus, M. L., and Heistad, D. D., 1981. Measurement of blood flow to bone and marrow in experimental animals by means of the microsphere technique, J. Bone Joint Surg. 63A:1028–1031.Google Scholar
  62. Gschneidner, K. A., Jr., 1991. Rare earths in the electronic industry, in: Fine Chemicals for the Electronic Industry. Chemical Applications for the 1990’s. (D. J. Ando and M. G. Pellat, eds.), Royal Society of Chemistry, London, pp. 63–94.Google Scholar
  63. Gupta, C. K., and Krishnan, T. S., eds., 1988. Rare Earths—Applications and Technology, Trans Tech Publ., Bombay.Google Scholar
  64. Gwinnett, A. J., 1967. Scandium as a target material in microradiography, J. Dent. Res. 46:1479.Google Scholar
  65. Habermeier, H.-U., 1992. YBeCuO high temperature superconductor thin film preparation by pulsed-laser deposition. Recent developments, Mater. Sci. Eng. B13:1–7.Google Scholar
  66. Häfeli, U. O., Pauer, G. J., Roberts, W. K., Humm, J. L., and Macklis, R. M., 1997. Magnetically targeted microspheres for intracavitary and intraspinal 90Y radiotherapy, Sci. Clin. Appl. Magnetic Carriers, Proc. Int. Conf, 1st, 1996 (U. Häfeli, ed.), Plenum Press, New York, pp. 501–516.Google Scholar
  67. Hamlin, R.L., Marsland, W.P., Smith, C.R., and Sapirstein, L.A., 1962. Fractional distribution of right ventricular output in the lungs of dogs, Circ. Res. 10:763–766Google Scholar
  68. Hara, T., and Freed, B. R., 1973. Preparation of carrier-free 47Sc by chemical separation from 47Ca and its distribution in tumor bearing mice, Int. J. Appl. Radiat, Isot. 24:373–376.Google Scholar
  69. Harrison, A., Walker, C, Parker, D., Jankowski, K., Cox, J., Craig, A., Sansom, J., Beeley, N., Boyce, R., Chaplin, L., Eaton, M., Farnsworth, A., Millar, K., Millican, A., Randall, A., Rhind, S., Secher, D., and Turner, A., 1991. The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates, Nucl. Med. Biol. 18:469–476.Google Scholar
  70. Harvey, J. C., Lee, K., and Beattie, E. J., 1993. Utility of the Nd:YAG laser for extensive pulmonary metastasectomy, J. Surg. Oncol. 54:175–179.Google Scholar
  71. Hayes, R. L., and Hübner, K. F., 1983. Basis for the clinical use of gallium and indium radionuclides, in: Metal Ions in Biological Systems (H. Sigel, ed.), Marcel Dekker, New York, Vol. 16, pp. 279–315.Google Scholar
  72. Hecht, J., 1987. Why scandium rose in value, New Scientist 114:26.Google Scholar
  73. Hedrick, J. B., 1993. Rare earths. The lanthanides, yttrium and scandium, US-DI Bureau of Mines, Washington, D.CGoogle Scholar
  74. Hedrick, J. B., 1996. Rare earths, Am. Ceram. Soc. Bull. 75:147–150.Google Scholar
  75. Herpst, J. M., Klein, J. L., Leichner, P. K., Quadri, S. M., and Vriesendorp, H. M., 1995. Survival of patients with resistant Hodgkin’s disease after polyclonal 90Y-labeled antiferritin treatment, J. Clin. Oncol. 13:2394–2400.Google Scholar
  76. Herzog, H., Rösch, F., Stöcklin, G., Lueders, C, Qaim, S. M., and Feinendegen, L. E., 1993. Measurement of pharmacokinetics of 86Y radiopharmaceuticals with PET and radiation dose calculation of analogous 90Y radiotherapeutics, J. Nucl. Med. 34:2222–2226.Google Scholar
  77. Himmelstein, J. S., and Levy, B. S., 1986. Environmental health aspects of the microelectronics industry. Occup. Med. 1:175–194.Google Scholar
  78. Hinton, T. G., Stoll, J. M., and Tobler, L., 1995. Soil contamination of plant surfaces from grazing and rainfall interactions, J. Environ. Radioact. 29:11–26.Google Scholar
  79. Hlatky, G. G., 1994. Oligomerization and polymerization by homogeneous catalysts, in: Encyclopedia of Inorganic Chemistry (R. B. King, ed.), John Wiley, Chichester, Vol., 5, pp. 2728–2740.Google Scholar
  80. Hnatowich, D. J., Virzi, R, and Doherty, P. W, 1985. DTPA-coupled antibodies labeled with 90Y, J. Nucl. Med. 26:503–509.Google Scholar
  81. Ho, S., Lau, W. Y., Leung, T. W., Chan, M., Ngar, Y. K., Johnson, P. J., and Li, A. K. C, 1996. Partition model for estimating radiation doses from 90Y microspheres in treating hepatic tumors, Eur. J. Nucl. Med. 23:948–952.Google Scholar
  82. Hoffman, C. G., 1991. Some alkali metals and scandium porphyrin derivatives, Thesis, University of California, Berkeley.Google Scholar
  83. Hoffmann, R., 1993. How should chemists think, Sci. Am. 2:66–73.Google Scholar
  84. Holz, R. C., and Horrocks, De W., Jr., 1990.89Y NMR spectrometry, a new probe for calcium-binding proteins, J. Magn. Reson. 89:627–631.Google Scholar
  85. Hopkins, K., Chandler, C, Bullimore, J., Sandeman, D., Coakham, H., and Kemshead, J. T., 1995. A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral 90Y radioimmunoconjugates, Radiother. Oncol. 34:21–31.Google Scholar
  86. Horwitz, P. E., and Dietz, M. L., 1994. Process for the separation and purification of 90Y for medical applications, U.S. patent 5368736. CA 122:64489m.Google Scholar
  87. Howell, R. W., Goddu, S. M., and Rao, D. V., 1994. Application of the linear-quadratic model to radioimmunotherapy. Further support for the advantage of longer-lived radionuclides. J. Nucl Med. 35:1861–1869.Google Scholar
  88. Huguenin, D., 1996. Use of doped yttrium, lutetium, or gadolinium tantalate in low voltage luminescence, European patent 690115. CA 124:130957g.Google Scholar
  89. Humm, J. L., 1986. Dosimetric aspects of radiolabeled antibodies for tumor therapy. J. Nucl. Med. 27:1490–1497.Google Scholar
  90. Hutcheson, D. P., Venugopal, B., Gray, D. H., and Luckey, T. D., 1979. Lanthanide markers in a single sample for nutrient studies in humans, J. Nutr. 109:702–707.Google Scholar
  91. Hutcheson, D. P., Kay, M., Enderle, M., Francis, R., and Luckey, T. D., 1983. The kinetics of lanthanide oxide markers in the alimentary tract of the pig, Nutr. Res. 3:913–921.Google Scholar
  92. Hyams, D. M., Esteban, J. M., LoUo, C. P., Beatty, B. G., and Beatty, J. D., 1987. Therapy of peritoneal carcinomatosis of human colon cancer xenografts with 90Y-labeled anti-CEA antibody ZCE 025, Arch. Surg. 122:1333–1337.Google Scholar
  93. Inoue, S., and Ohtaki, N., 1994. Metaphosphates as packing materials for biochromatography, J. Chromatogr. 679A:247–253.Google Scholar
  94. Irion, G. L., Wolfson, M. R., and Alsberge, M. S., 1988. Computerized stripping method for multiple nuclide microsphere studies, Comput. Biomed. Res. 21:27–37.Google Scholar
  95. Ishihara, K., Kubota, M., Kurihara, H., and Yamamoto, H., 1995. Scandium trifluoromethanesulfonate as an extremely active acylation catalyst, J. Am. Chem. Soc. 117:4413–4414.Google Scholar
  96. Ishiwata, S., Kimura, E., and Nakanishi, H., 1990. Preparation and applications of scandium compounds, in: Rare Metals’ 90, Proc. Symp. Osaka, pp. 53–56.Google Scholar
  97. Janson, P. O., 1975. Effects of the luteinizing hormone on blood flow in the follicular rabbit ovary, as measured by radioactive microspheres, Acta Endocrin. 79:122–133.Google Scholar
  98. Jones, R. L., 1990. Oxide acid-base reaction in ceramic corrosion, High Temp. Sci. 27:369–380.Google Scholar
  99. Kairemo, K., Ljunggren, K., Strand, S. E., Hiltunen, J., Pentola, P., Nikula, T., Laine, A., and Wahlström, T., 1993. Radioimmunotherapy with 90Y-labeled M Ab in a nude mouse ovarian cancer model, Acta Oncol. 32:801–805.Google Scholar
  100. Kairento, A. L., Brownell, G. L., Schluederberg, J., and Elmaleh, D. R., 1983. Regional blood-flow measurement in rabbit soft-tissue tumor with positron imaging using the C15O2 steady-state and labeled microspheres, J. Nucl. Med. 24:1135–1142.Google Scholar
  101. Keeling, A. A., and Beaney, R. P., 1991. 87Y for in vivo imaging, Nucl. Med. Biol. 18:261–262.Google Scholar
  102. Keeling, A. A., Vaughan, A. T. M., and Beaney, R. P., 1989. 90Y-EDTMP: A radiotherapeutic agent in the treatment of leukaemias, Br. J. Cancer 60:74–78.Google Scholar
  103. Kim, S., Dorscher-Kim, J., Liu, M. T., and Trowbridge, H. O., 1988. Biphasic pulp blood-flow response to substance P in the dog as measured with a radiolabelled microsphere injection method, Arch. Oral Biol. 33:305–309.Google Scholar
  104. Kishan, J., Gupta, B. N., Arora, S. P., and Chopra, R. C., 1982. Measurement of rumen dry matter passage and turnover rate in buffaloes fed on various ration combination using 46Sc, J. Nucl. Agric.Biol. 11:5–7.Google Scholar
  105. Klein, J. L., et al., 1989. 90Y and 131I radioimmunoglobulin therapy of an experimental human hepatoma, Cancer Res. 49:6383–6389.Google Scholar
  106. Kobayashi, S., Hachiya, I., Ishitani, H., and Araki, M., 1997. Scandium trifluoromethanesulfonate as a novel reusable Lewis acid catalyst in aldol and Michael reactions, Synlett 1:412–414.Google Scholar
  107. Kohner, E. M., Dollery, C. T., and Bulpitt, C. J., 1969. Cotton-wool spots in diabetic retinopathy, Diabetes 18:691–704.Google Scholar
  108. Komissarova, L. N., Mel’nikov, P. P., Pushkina, G. Ya., Karavajko, G. I., Avakyan, Z. A., and Voronchikhin, D. A., 1995. Use of fungi for extracting rare earth elements and especially scandium from phosphorus-containing mineral raw materials, Russian patent 2036.148. CA 123:346249e.Google Scholar
  109. Koral, K. F., Kwok, C. S., Yang, F. E., Brown, R. S., Sisson, J. C, and Wahl, R. L., 1993. Autoradiography-based, three-dimensional calculation of dose rate for murine, human-tumor xenographts, Nucl. Med. Biol. 20:901–909.Google Scholar
  110. Kosmas, C., Maraveyas, A., Gooden, C. S., Snook, D., and Epenetos, A. A., 1995. Anti-chelate antibodies after intraperitoneal 90Y-labeled MAb immunoconjugates for ovarian cancer therapy, J. Nucl. Med. 36:746–753.Google Scholar
  111. Kroyer, K., Bülow, J., Nielsen, S. L., and Kromann-Andersen, B., 1990. Urinary bladder blood flow. 1. Comparison of clearance of locally injected 99mTc pertechnate and radioactive microsphere technique in dogs, Urol. Res. 18:223–226.Google Scholar
  112. Kudo, Y., 1988. Industrial applications of rare earths in Japan, in: Rare Earths. Applications and Technology (C. K. Gupta and T. S. Krishnan, eds.), Translations of Technical Publications, Switzerland, pp. 243–258.Google Scholar
  113. Kudoh, Y., Hearse, D. J., Maxwell, M. P., Yoshida, S., Downey, J. M., and Yellon, D. M., 1986. Calcium antagonists and myocardial infarction, J. Mol Cell. Cardiol. 18 (Suppl. 4):77–92.Google Scholar
  114. L’Abbate, A. Camici, P., Pelosi, G., Trivella, G., Valli, G., Marzilli, M., Levantesi, D., and Taddei, L., 1961. A new technique for multitracer macroscopic autoradiography, J. Nucl Med. Allied Sci. 25:27–33.Google Scholar
  115. Ladany, I., Zanzucchi, P. J., Andrews, J. T., Kane, J., and De Piano, E., 1986. Scandium oxide antireflection coatings for superluminescent LEDS, Appl Opt. 25:472–473.Google Scholar
  116. Lamb, K. P., Hassan, E., and Scotter, D. R., 1971. Dispersal of 46Sc-labelled Pantorhytes weevils in Papuan cacao plantations, Ecology 52:178–182.Google Scholar
  117. Lange, M., Kirsch, C. M., Steude, U., and Oeckler, R., 1995. Intracavitary treatment of intrasellar cystic craniopharyngiomas with 90Y by trans-spheroidal approach, Acta Neurochir. 135:206–209.Google Scholar
  118. Lehtola, A., Kivilaakso, E., Puolakkainen, P., Karonen, S.-L., Lempinen, M., and Schröder, T., 1986. Effects of dextran 70 versus crystalloids in the microcirculation of porcine hemorrhagic pancreatitis, Surg. Gynecol Obstet. 162:556–562.Google Scholar
  119. Lengemann, F. W., Grieve, R. B., Chmielewicz, M., and Georgi, J. R., 1986. 203Hg and other gamma-emitting radio-isotopes as labels for Dirofilaria immitis microfilaria, Parasitology92:451–461.Google Scholar
  120. Lin, W. Y, Wang, S. J., Chen, M. N., Shen, L. H., Tsai, Z. T., and Ting, G., 1995. Preparation and biodistribution of 90Y lipidol in rats following hepatic arterial injection, J. Nucl Med. 36:163P.Google Scholar
  121. Ljunggren, K., and Strand, S. E., 1991. Imaging detector for static and dynamic studies in biological samples, Nucl. Instrum. Methods Phys. Res. 31A:475-478.Google Scholar
  122. Luckey, T. D., Venugopal, B., Gray, D., and Hutcheson, D., 1977. Lanthanide marker evidence for one and two physiologic compartments in the human alimentary tract, Nutr. Rep. Int. 16:339–347.Google Scholar
  123. Macklis, R. M., Beresford, B. A., and Humm, J. L., 1994. Radiobiologic studies of low-dose-rate 90Y-lymphoma therapy, Cancer 73(Suppl. 3):966–973.Google Scholar
  124. MacSweeney, J. E., Baxter, M. A., and Joplin, G. E, 1990. Heel pad thickness is an insensitive index of biochemical remission in acromegaly, Clin. Radiol. 42:348–350.Google Scholar
  125. Mantravadi, R. V., Spigos, D. G., Tan, W. S., and Felix, E. L., 1982. Intraarterial 90Y in the treatment of hepatic malignancy, Radiology 142:783–1776.Google Scholar
  126. Maraveyas, A., Myers, M., Stafford, N., Rowlinson-Busza, G., and Stewart, J. S. W., 1995. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer. Reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues, Cancer Res. 55:1020–1027.Google Scholar
  127. Mardirossian, G., Wu, C, and Hnatowich, D. J., 1993. The stability in liver homogenates of 111In and 90Y attached to antibody via two popular chelators, Nucl. Med. Biol. 20:65–74.Google Scholar
  128. Maurel, J. C., and Masse, J. P., 1991. New organic derivatives of metals with phospholipids, use of these derivatives, process for isolating the derivatives from plants, and pharmaceutical compositions containing them, PCT patent. CA 116:28114c.Google Scholar
  129. McCalden, T. A., 1979. Serial measurement of cerebral blood flow using external counting of microspheres, Stroke 10:29–33.Google Scholar
  130. McCredie, D. A. Troehler, U., and Bonjour, J. P., 1984. In vivo determination of intestinal calcium absorption with 47Sc used as marker, J. Lab. Clin. Med. 103:354–362.Google Scholar
  131. Meares, C. E, Li, M., and DeNardo, S. J., 1995. Method for preparing radionuclide-labeled chelating agents for ESR and NMR, PCT patent 9526206. CA 124:49701x.Google Scholar
  132. Medvedev, O. S., Martynova, E. R., Akchurin, R. S., and Khalatov, V Yu., 1987. Experimental estimation of chronic microsphere loss from the rat myocardium, Bull. Exp. Biol. Med. 103:7–9.Google Scholar
  133. Miller, J. K., and Byrne, W. E., 1970. Comparison of 46Sc and 144Ce as nonabsorbed reference materials in studies with cattle, J. Nutr. 100:1287–1291.Google Scholar
  134. Miller, J. K., Byrne, W. E, and Lyke, W. A., 1972. Comparison of fecal excretions of 46Sc tagged sand and soluble 144Ce by calves, Health Phys. 22:461–465.Google Scholar
  135. Mirza, M. Y, and Aziz, A., 1969. A scandium generator, Radiochim. Acta 11:43–44.Google Scholar
  136. Mirzadeh, S., Schenter, R. E., Callahan, A. P., and (Russ) Knapp, E E, Jr., 1992. Production capabilities in US nuclear reactors for medical radioisotopes, Oak Ridge National Laboratory, Report ORNL/TM-12010, Oak Ridge, Tennessee.Google Scholar
  137. Mirzoyan, G. S., et al., 1995. Steel alloyed with yttrium, Russian patent 2048590. CA 124:295443z.Google Scholar
  138. Molinatti, G. M., Camanni, E, Massara, E, and Messina, M., 1967. Implantation of the sella turcica with 90Y in the treatment of Cushing’s syndrome of pituitary origin, J. Clin. Endocr. 27:861–876.Google Scholar
  139. Morgan, A., Holmes, A., and Gold, C., 1971. Studies of the solubility of constituents of chrysotile asbestos in vivo using radioactive tracer techniques, Environ. Res. 4:558–570.Google Scholar
  140. Mori, E., and Takanashi, R., 1992. Nonradioactive element-containing microspheres for determining blood flow in tissues or organs. Japanese patent 04 05244. CA 116:190663c.Google Scholar
  141. Morrow, J., R., 1996. Hydrolytic cleavage of RNA catalyzed by metal ion complexes, in Metal Ions in Biological Systems, (A. Sigel and H. Sigel, eds.), Marcel Dekker, New York, Vol. 33, pp. 561–592.Google Scholar
  142. Murray, J. R., 1987. Lasers for spectroscopy, in: Laser Spectroscopy and Its Applications, (L. J. Radziewski, R. W. Solarz, and J. A. Paisner, eds.), Marcel Dekker, New York, pp. 91–174.Google Scholar
  143. Myers, S., Sparks, J. W., and Makovski, E. L., 1986. Factors affecting radioactive microsphere measurements of blood flow in pregnant guinea pigs, Lab. Anim. Sci. 36:522–526.Google Scholar
  144. Nother, G., 1959. A technique for destruction of the hypophyses using 90Y spheres, Acta Radiol. 184 (Suppl.): 1–128.Google Scholar
  145. Ogg, C. S., Pearson, J. D., and Veall, N., 1968. A method for measuring the gastrointestinal absorption of 47Ca using 47Sc as an inert marker, Clin. Sci. 34:327–332.Google Scholar
  146. O’Neill, L., Murphy, M., and Gallagher, R. B., 1994. What are we? Where did we come from? Where are we going? Science 263:181–183.Google Scholar
  147. Order, S. E., Klein, J. L., Leichner, P. K., Frincke, J. M., Lollo, C., and Carlo, D. J., 1986. 90Y antiferritin. A new therapeutic radiolabelled antibody, Int. J. Radiat Oncol Biol 12:277–281.Google Scholar
  148. Oshikawa, S., Suzuki, M., Amihoshi, J., and Hirayama, G., 1995. Two wavelength antireflection film, Japanese patent 07 244204. CA 123:35427z.Google Scholar
  149. Pandey, R. K., Sing, K. P., and Rathore, V. S., 1996. Measurement of thickness and water content of soybean leaves by beta gauging, J. Nucl Agric. Biol. 25:1–8.Google Scholar
  150. Pearson, J. D., 1966. Use of 51Cr-labelled haemoglobin and 47Sc as inert faecal markers, Int. J. Appl. Radiat, Isot. 17:13–16.Google Scholar
  151. Perry, D. L., and Phillips, S. L., eds., 1995. Handbook of Inorganic Compounds, CRC Press, Boca Raton, Florida, pp. 341–342, 445-448.Google Scholar
  152. Pond, K. R., Ellis, W. C., James, W. D., and Deswysen, A. G., 1985. Analysis of multiple markers in nutrition research, J. Dairy Sci. 68:745–750.Google Scholar
  153. Quink, T. F., Abbott, H. G., and Meilen, W. J., 1970. Locating tree seed caches of small mammals with a radioisotope, For. Sci. 16:147–148.Google Scholar
  154. Rakovic, M., Pouckova, P., and Silar, J., 1991. Can yttrium ions serve as a tumor localizer? Isotopenpraxis 27:332–334.Google Scholar
  155. Rayman, R. R., Clavo, A. C., Crawford, S. C., Recker, B., and Wahl, R. L., 1997. Magnetically-enhanced radionuclide therapy (MERIT). In vitro evaluation. Int. J. Radial Oncol. Biol Phys. 37:1201–1206.Google Scholar
  156. Reardon, D. T., Meares, C. F., Goodwin, D. A., McTigue, M., David, G. S., Stone, M. R., Leung, J. P., Bartholomew, R. M., and Frincke, J. M., 1985. Antibodies against metal chelates, Nature 316:265–268.Google Scholar
  157. Rehder, D., and Hink, K., 1989. The interaction of Sc(OH)2+.aq with serine and small peptides investigated by 45Sc NMR spectroscopy, Inorg. Chim. Acta 158:265–271.Google Scholar
  158. Remmenga, S. W., Colcher, D., Gansow, O., Pippen, C. G., and Raubitschek, A., 1994. Continuous effusion chemotherapy as a radiation-enhancing agent for 90Y-radiolabelled MAb therapy of a human tumor xenograft, Gynecol Oncol 55:115–122.Google Scholar
  159. Roberson, P. L., Ten Haken, R. K., McShan, D. L., McKeever, P. E., and Ensminger, W. D., 1992. Three-dimensional tumor dosimetry for hepatic 90Y-microsphere therapy, J. Nucl. Med. 33:735–738.Google Scholar
  160. Rösch, F., Herzog, H., Plag, C, Neumaier, B., Braun, U, Mùller-Gartner, H.-W., and Stöcklin, G., 1996. Radiation doses of 90Y citrate and 90Y EDTMP as determined via analogues 86Y complexes and positron emission tomography, Eur. J. Nucl Med. 23:958–966.Google Scholar
  161. Roselli, M., Schlom, J., Gansow, O. A., Raubitschek, A., Mirzadeh, S., Brechbiel, M. W., and Colcher, D., 1989. Comparative biodistributions of yttrium-and indium-labeled MAb B72.3 in athymic mice bearing human colon carcinoma xenografts, J. Nucl. Med. 30:672–682.Google Scholar
  162. Roskill Information Services, 1985. The Economics of Scandium, Roskill Information Services, London.Google Scholar
  163. Rowlinson-Busza, G., Snook, D., and Epenetos, A. A., 1994. 90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTA, Int. J. Radiat. Oncol. Biol. Phys. 28:1257–1265.Google Scholar
  164. Rubin, R. H., and Strauss, W. H., 1987. Method for the diagnosis and treatment of inflammations using labeled immuno-globulins, PCT patent 87.04.351.Google Scholar
  165. Salako, Q. A., and DeNardo, S. J., 1997. Radioassay of 90Y radiation using the radionuclide dose calibrator. J. Nucl. Med. 38:723–726.Google Scholar
  166. Salashchenko, N. N., and Shamov, E. A., 1997. Short-period x-ray multiplayers based on CrSc, Opt. Commun. 134:7–10. CA 126:110536g.Google Scholar
  167. Sawada, Y, Patlak, C. S., and Blasberg, R. G., 1989. Kinetic analysis of cerebro-vascular transport based on indicator diffusion technique, Am. J. Physiol. 256:794–812.Google Scholar
  168. Sax, S., and Lewis, R. J., 1992. Dangerous Properties of Industrial Materials, Van Nostrand Reinhold, New York.Google Scholar
  169. Scheinberg, D. A., Strand, M., and Gansow, O. A., 1982. Tumor imaging with radioactive metal chelates conjugated to MAb, Science 215:1511–1513.Google Scholar
  170. Schmidberger, H., Buchsbaum, D. J., Blazar, B. R., Everson, P., and Vallerà, D. A., 1991. Radiotherapy in mice with 90Y-labeled anti-Lyl MAb, Cancer Res. 51:1883–1890.Google Scholar
  171. Schubiger, P. A. Beer, H.-R., Geiger, L., Rosier, H., Zimmermann, A., Triller, J., Mettler, D., and Schilt, W., 1991. 90Y-resin particles. Animal experiments on pigs with regard to the introduction of superselective embolization therapy, Nucl. Med. Biol. 18:305–311.Google Scholar
  172. Shanberg, A, M., Lee, I. S., Tansey, L. A., and Sawyer, D. E., 1994. Depth of penetration of the Nd:YAG laser in the human prostate at various dosimetry, Urology 43:809–812.Google Scholar
  173. Shapshay, S., Aretz, H. T., and Setzer, S. E., 1990. Soft tissue effects of the Ho:SGG laser in the canine trachea, Otolaryngol Head Neck Surg. 102:251–256.Google Scholar
  174. Shen, S., DeNardo, G. L., Yuan, A., DeNardo, D. A., and DeNardo, S.J., 1994. Planar gamma camera imaging and quantitation of 90Y bremsstrahlung. J. Nucl. Med. 35:1381–1389.Google Scholar
  175. Sheridan, M., and Tamarin, R. H., 1986. Kinships in a natural meadow vole population, Behav Ecol. Sociobiol. 29:207–211.Google Scholar
  176. Shimizu, Y., 1993. Antimicrobial antifouling thermoplastic articles and their manufacture, Japanese patent 05163382. CA 119:205168h.Google Scholar
  177. Singleton, J. H., and Yannopoulos, L. N., 1975. The use of yttrium and scandium for fabrication of radioactive electron emitters, J. Vac. Sci. Technol. 12:414–418.Google Scholar
  178. Skarstein, A., 1979. Effect of indomethain on blood flow distribution in the stomach of cats with acute gastric ulcer, Scand. J. Gastroenterol. 14:905–911.Google Scholar
  179. Smith, T., Veall, N., and Wootton, R., 1982. Bladder wall dose from administered radio pharmaceuticals. Radiat. Protein Dosim. 2:183–189.Google Scholar
  180. Snook, D. E., Rowlinson-Busza, G., Meares, C, and Epenetos, A. A., 1991. 111In and 90Y-labeled macrocycle chelating agents, in: Monoclonal Antibodies (A. A. Epenetos, ed.), Chapman & Hall Medical, London, pp. 157–166.Google Scholar
  181. Soloway, A. H., Balcius, J. F., and Ojemann, R. G., 1963. Separation of 49Sc from a calcium target, Int. J. Appl. Radiat, hot. 14:245–249.Google Scholar
  182. Spivak, J. M., Grande, D. A., Ben-Yishay, A., Menche, D. S., and Pitman, M. I., 1992. The effect of low-level Nd:YAG laser energy on adult articular cartilage in vitro, Arthroscopy 8:36–43.Google Scholar
  183. Stein, R., Blumenthal, R., Sharkey, R. M., and Goldenberg, D. M., 1994. Comparative biodistribution and radioimmunotherapy of MAb RS7 and its F(ab′)2 in nude mice bearing human tumor xenografts, Cancer 73:816–823.Google Scholar
  184. Sterenborg, H. J. C. M., Van den Akker, H. P., van der Meulen, F., W., Van Swol, C. F. P., Van Leeuwen, A. G. J. M., and Van Genert, M. J. C., 1990. Laser lithotripsy of salivary stones. A comparison between the pulsed dye laser and the Ho:YSGG laser, Lasers Med. Sci. 5:357–363.Google Scholar
  185. St. Raymond, P. A., 1990. 47Sc chelated MAb, PhD thesis, University of Maryland. Diss. Abstr. 52:873b.Google Scholar
  186. Su, Q. I., 1991. Yttrium, its applications, separation, in: Rare Earth Minerals and Minerals for Electronic Uses (B. Siribumrungskha et al., eds.), Translations of Technical Publishers, Switzerland, pp. 421–431.Google Scholar
  187. Syed, I. B., and Hosain, F., 1975. 44Sc A possible new radionuclide for bone scanning, Appl. Radiol 3-4:82–83.Google Scholar
  188. Talairach, I., and Szikla, G., 1965. Neurochirurgy 11:233, cited by V F. Terekhova and E. M. Savitski, 1975, Yttrium, Israel Program Scientific Translations, Jerusalem.Google Scholar
  189. Tetens, J., Tulleners, E. P., Ross, M. W., Orsini, P. G., and Martin, B. B., Jr., 1994. Transendoscopic contact Nd:YAG laser treatment of tympany of the auditory tube diverticulum in two foals, J. Am. Vet. Med. Assoc. 204:1927–1929.Google Scholar
  190. Thakur, M. L., 1990. Novel use of a radiolabeled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals, U.S. patent 4917878. CA 113:128752r.Google Scholar
  191. Tian, J.-H., Xu, B.-X., Zhang, J.-M., Dong, B.-W., Ping, L., and Wang, X.-D., 1996. Ultrasound-guided internal radiotherapy using 90Y-glass microspheres for liver malignancies, J. Nucl. Med. 37:958–963.Google Scholar
  192. Tilyou, S. M., 1991. 90Y for cancer therapy studies secured through government and commercial suppliers, J. Nucl. Med. 32:16–20.Google Scholar
  193. Tomenius, L., 1973. A method for determining the retention of inhaled particles in a bronchus, Environ. Physiol. Biochem. 3:1–12.Google Scholar
  194. U.S. Food and Drug Administration (FDA), 1993. Indirect food additives: Polymers, Fed. Register 58:48598–48599. CA 120:7087p.Google Scholar
  195. Vallera, D. A., Schmidberger, H., Buchsbaum, D. J., Everson, P., Snover, D. C, and Blazar, B. R., 1991. Radiotherapy in mice with 90Y-labeled anti-Lyl MAb. Therapy of established graft-versus-host disease induced across the major histocompatibility barrier, Cancer Res. 51:1891–1897.Google Scholar
  196. Vander, W., and Stephen, B., 1995. Dynamics of yellow pine chipmunk (Tamias amoenus) seed caches. Ecoscience 2:261–266.Google Scholar
  197. Vaughan, A. T. M., Yankuba, S. C. S., and Anderson, P., 1987. Antibodies labeled with metallic radionuclides, Natl. Cancer Inst. Monogr. 3:141–144.Google Scholar
  198. Vogtle, F., 1991. Supramolecular Chemistry. An Introduction, John Wiley and Sons, Chichester.Google Scholar
  199. Vriesendorp, H. M., Quadri, S. M., Andersdon, B. S., and Dicke, K. A., 1996. Hematologic side effects of radiolabeled immunoglobulin therapy, Exp. Hematol. 24:1183–1190.Google Scholar
  200. Wehner, A. P., Wilkerson, C, L., Mahaffey, J. A., and Millman, E. M., 1980. Fate of inhaled fly ash in hamsters, Environ. Res. 22:485–498.Google Scholar
  201. White, C. A., Halpern, S. E., Parker, B. A., Miller, R. A., Hupf, H. B., Shawler, D. L., Collins, H. A., and Royston, I., 1996. Radioimmunotherapy of relapsed B-cell lymphoma with 90Y anti-idiotype MAb, Blood 87:3640–3649.Google Scholar
  202. Wiener, C. M., Kirk, W, and Albert, R. K., 1990. Prone position reverse gravitational distribution in dog lungs with oleic acid-induced injury, J. Appl. Physiol. 468:1386–1392.Google Scholar
  203. Wike, J. S., Guyer, C. E., Ramey, D. W, and Phillips, B. P., 1990. Chemistry for commercial scale production of 90Y for medical research, Appl Radiat. Isot. 41:861–863.Google Scholar
  204. Wilson, E. D., 1998. Consilience, The Unity of Knowledge, Alfred A. Knopf, New York.Google Scholar
  205. Wollner, L., Knutsen, C, Smith, P., Prieston, D., Chrisp, C, Andrews, J., Juni, J., Warber, S., Klevering, J., Crudup, J., and Ensminger, W, 1988. Effects of hepatic arterial 90Y glass microspheres on dogs. Cancer 61:1336–1344.Google Scholar
  206. Wu, C, Virzi, F., and Hnatowich, D. J., 1992. Investigations of N-linked macrocycles for 111In and 90Y labeling proteins, Nucl. Med. Biol. 19:239–244.Google Scholar
  207. Wu, E., 1989. Plant virucides, insecticides and growth regulators containing triacontanol, Chinese patent 1030857. CA 113:54365t.Google Scholar
  208. Xi, W., Tang, F., He, X., and Li, Z., 1996. Influence of sintering process and doping on properties of hydroxyapatite ceramics, Gongneng Cailiao 27:274–276 (Chinese). CA 126:175427s.Google Scholar
  209. Xu, G and Xiao, J., eds, 1985. New Frontiers in Rare Earth Science and Applications, Science Press, Beijing, Vols. 1 and 2.Google Scholar
  210. Xu, Y, 1992. Lanthanide fluorescence assay for bioaffinity compounds, PCT patent 9216840. CA 118:76599c.Google Scholar
  211. Yamamoto, H., and Ishihara, K., 1996. Method for producing esters, Japanese patent 08157416. CA 125:194720c.Google Scholar
  212. Yamamoto, H., and Ishihara, K., 1998. Preparation of acetals using scandium complexes, Japanese patent 10 45657. CA 128:204619e.Google Scholar
  213. Yan, S.-C. P., Zhou, Z.-Z., and Wu, Y.-D., 1985. Application of scandium oxide in an electron emission material, in: New Frontiers in Rare Earth Science and Application (G. Xu and J. Xiao, eds.), Science Press, Beijing, Vol.2, pp. 1476–1480.Google Scholar
  214. Yan, Z. P., Lin, G., Zhao, H. I., and Dong, Y. H., 1993. 90Y glass microspheres injected via the portal vein, Acta Radiol 34:395–398.Google Scholar
  215. Yang, X., 1991. Laser ablation of human arterial atheromas with the Nd:YAG laser, PhD thesis, Kuopio University, Finland, 79 pp, Diss. Abstr. Int. 53:322C.Google Scholar
  216. Zamora, P., and Griffith, J. K., 1995. Fusion proteins containing metallothionein and targeting-protein structural components, PCT patent 9504753. CA 122:283859k.Google Scholar
  217. Zharikov, E. V., 1991. Growth features of rare earth scandium garnets, Proc. Ind. Natl Sci. Acad. 57:117–124.Google Scholar

Suggested Further Reading

  1. Amols, H. I., Reunstein, L. E., and Weinberger, J., 1996. Dosimetry of a radioactive balloon dilatation catheter for treatment of neointimal hyperplasia, Med. Phys. 23:1783–1796.Google Scholar
  2. Asavatanabodee, P., Sholten, D., and Davis, P., 1997. 90Y radiochemical synovectomy in chronic knee synovitis, J. Rheumatol. 24:639–642.Google Scholar
  3. Cavouras, D., Kandarakis, I., Panayotakis, G. S., Evangelou, E. K., and Nomicos, C. D., 1996. An evaluation of the Y2O3:Eu3+ scintillator for application in medical x-ray detectors and image receptors, Med. Phys. 23:1965–1975.Google Scholar
  4. Chinol, M., Franceschini, R., Paganelli, G., Pecorale, A., and Paiano, A., 1997. Simple production of 90Y in a chemical form suitable to clinical grade radio conjugates, Radioact. Isot. Clin. Med. Res., Proc. Int. Badgastein Symp., 22nd, pp. 327–332.Google Scholar
  5. Cremonesi, M., Ferrari, M., Chinol, M., Stabin, M. G., Grana, C, Prisco, G., Robertson, C, Tosi, G., and Paganeli, G., 1999. Three-step radioimmunotherapy with 90Y biotin: Dosimetry and pharmakinetics in cancer patients, Eur. J. Nucl. Med. 26:110–120.Google Scholar
  6. De Lacharriere, O., and Breton, L., 1997. Salts of lanthanides, tin, zinc, manganese, yttrium, cobalt, barium, strontium in a skin care composition, Canadian patent 2188688. CA 127:210205n.Google Scholar
  7. Griffits, G. L., and Hansen, H. J., 1997. Targeted combination immunotherapy of cancer, PCT patent 9741898. CA 128:39530j.Google Scholar
  8. Ishido, M., and Okada, S., 1997. Method for manufacture of scandium with low a radiation and low oxygen content, Japanese patent 09324227. CA 128:64311.Google Scholar
  9. Jahangie, Z. N., Jacobs, J. W. G., Van Isselt, J. W, and Bijlsma, J. W. J., 1997. Persistent synovitis treated with radiation synovectomy using 90Y. A retrospective evaluation of 83 procedures for 45 patients, Br. J. Rheumatol. 36:861–869.Google Scholar
  10. Kobayashi, S., ed., 1999. Lanthanides: Chemistry and Use in Organic Synthesis, Springer Verlag, Berlin.Google Scholar
  11. Lau, W. Y, Ho, S., Leung, T. W. T, Ho, R., Johnson, P. J., and Li, A. K., 1998. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90Y microspheres, Int. J. Radiat. Oncol. Biol. Phys. 40:583–592.Google Scholar
  12. Leavitt, R. D., and Avila, L. Z., 1997. Polymeric delivery of radio nuclides and radio pharmaceuticals, PCT patent 9733628. CA 127:283401h.Google Scholar
  13. Leichner, P. K., Akabani, G., Colcher, D., Harrison, K., Hawkins, W., Eckblade, M., Baranowska-Kortylewicz, J., Augustine, S., Wisecarver, J., and Tempere, M., 1997. Patient-specific dosimetry of 111In and 89Y-labeled monoclonal antibody CC49, J. Nucl. Med. 38:512–516.Google Scholar
  14. Mamers, H., and McCarthy, K. J., 1998. Preparation and testing of diffusable metal chelate fungicides, Holzforschung 52:18–26.Google Scholar
  15. Mausner, L. F., Kolsky, K. L., Joshi, V., and Srivastava, S. C., 1998. Radionuclide development at BNL for nuclear medicine therapy, Appl. Radial Isot. 49:285–294.Google Scholar
  16. Paganelli, G., Grana, C., Chinol, M., Cremonesi, M., De Cicco, C., Robertson, C., and Veronesi, U., 1999. Antibody-guided three-step therapy for high grade glioma with 90Y biotin, Eur. J. Nucl. Med. 26:348–357.Google Scholar
  17. Platzek, J., Speck, U., and Niedballa, U., 1999. Lipophilic metal complexes for necrosis infarct imaging, PCT patent WO99-16.473. CA 130:27893s.Google Scholar
  18. Qian, W., and Laurence, P. C., 1996. A restoration algorithm for 32P and 90Y bremsstrahlung emission nuclear imaging, Med. Phys. 23:1309–1323.Google Scholar
  19. Ripert, V., Papiernik, R., Hubert-Pfalzgraf, L. G., and Belleville, P., 1998. The quest for nanosized crystalline colloidal suspensions of scandium and yttrium oxide for optical applications, 215th ACS National Meeting, Dallas, March 29-April 2, 1998, Abstr. Inorg. 540.Google Scholar
  20. Rösch, F., Herzog, H., Stolz, B., Brockmann, J., Köhle, M., Möhlensiepen, H., Marbach, P., and Möller-Gärtner, H. W., 1999. Stability, uptake kinetics and radiation doses of the somatostatin receptor ligand [86Y]DOTA-DPhe1-Tyr3-octreotide using positron-emission-tomography in nonhuman primates, Eur. J. Nucl. Med. 26:358–366.Google Scholar
  21. Semenov, S. A., Reznik, A. M., and Bukin, V I., 1997. Technological aspects of scandium raw material resources, Izv. Vyssh. Uchebn. Zaved. Tsvetn. Metall 1997(6):23–25 (Russian).Google Scholar
  22. Shukla, S. K., Limouris, G. S., Cusumano, R., Acconcia, A., Cipriani, A., Atzei, G., Argiro, G., and Boemi, S., 1997. Advanced prostate cancer diagnosis and therapy with 67Ga and 90Y, respectively, Anticancer Res. 17:1731–1734.Google Scholar
  23. Sills, J. M., and Nagle, C. C, 1998. Extrapolation of 90Y and 90Sr activity in older fuel fragments using a vented ion chamber, Radial Prot. Manage. 15:53–64.Google Scholar
  24. Soto, J., and Patton, J. T., 1997. Yttrium containing metal complexes and olefin polymerization process, PCT patent 9743294. CA 128:35159x.Google Scholar
  25. Teichman, J. M. H., Rogenes, V J., Mciver, B. J., and Harris, J. M., 1997. Holmium-yttrium-aluminum garnet laser cystolithotripsy of large bladder calculi, Urology 50:44–48.Google Scholar
  26. Todorova, G. K., and Apblett, A. W., 1997. Synthesis and properties of yttrium metaloorganic polymers, 213th ACS National Meeting, San Francisco, April 13-17, 1997, Abstr. Inorg. 612.Google Scholar
  27. Voges, J., Sturm, V, Treuer, H., Gauss, C, and Berthold, F., 1997. Cystic craniopharyngioma. Long-term results after intracavitary irradiation with stereotactically applied colloidal β-emitting radioactive sources, Neurosurgery 40:263–270.Google Scholar
  28. Watanabe, N., Oriuchi, N., Igarashi, H., Higuchi, T., Yukihiro, M., Fukushima, Y, Tomivoshi, K., Hirano, T., Inoue, T., and Endo, K., 1997. Preparation of 90Y-labeled human macro aggregated albumin for regional radiotherapy, Nucl. Med. Biol. 24:465–469.Google Scholar
  29. Zhang, J., 1997. Manufacture of superhigh-purity yttrium oxide, Chinese patent 1140148. CA 128:259097p.Google Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Chaim T. Horovitz
    • 1
  1. 1.RehovotIsrael

Personalised recommendations